Montara Therapeutics
PrivateLast Round
Grant
May 21, 2025
Total Funding Raised
$39.3M
Momentum Score
75 /100
Company Overview
Montara Therapeutics is a biotechnology company that develops a precision pharmacology platform aimed at creating innovative therapies for central nervous system diseases by utilizing human genetics and machine learning to identify and validate drug targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Montara Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Montara Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 21, 2025 | ||||
| Seed | Mar 13, 2025 | ||||
| Seed | Jul 30, 2024 | ||||
| Seed | Jan 19, 2024 |
Key People
Founding team and executive leadership
Montara Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BEVC | Seed |
| Dolby Family Ventures | Seed |
| Two Bear Capital | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| KdT Ventures | Seed |
| The Dementia Discovery Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
Partnering with the TSC Alliance to advance lead program.
- Dec 8, 2025
Initial data on MT1110-everolimus combination presented at AES Annual Meeting.
Montara Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Montara Therapeutics's valuation, stock price, and market status.
